Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Melatonin (N05Ch01), Excluding Prolonged-Release Tablets With An Effective Strength Of 2Mg As Part Of A So-Called Open-House Model.

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 80910751

  Document Type - Tender Notices

Description - Description: Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicines with the active ingredient melatonin (N05CH01), excluding prolonged-release tablets with an effective stren gth of 2mg within the period from June 1st, 2024 to May 31st, 2026 with the possibility of doing so at any time Conclusion of contract (open-house model). In the open house procedure, medicines according to the BfArM list according to Section 35 Para. 5a SGB V (childrens medicines) are excluded.local title:: Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Melatonin (N05CH01)

Gt Ref Id - 80910751

Deadline - Mar 31, 2026